Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study
Medicina · 19.05.2026 · 62 (5) · 992
DOI: 10.3390/medicina62050992 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medicina, online erschienen am 19.05.2026. Verfasst von Anıl Karakayalı und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Clinic, Faculty of Medicine, Kocaeli City Hospital, İzmit 41060, Turkey. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Nutrition Assessment. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and Objectives: Neoadjuvant chemotherapy (NAC) followed by radical cystectomy is the standard of care for eligible patients with locally advanced bladder cancer (LABC). However, adjuvant chemotherapy (AC) remains widely used in real-world practice. Host-related inflammatory and nutritional biomarkers may also influence survival outcomes. This study aimed to compare survival outcomes between NAC and AC and to identify independent prognostic factors for overall survival (OS) and progression-free survival (PFS), with particular emphasis on the Prognostic Nutritional Index (PNI).
Methods
This multicenter retrospective study included 262 patients with locally advanced bladder cancer. The median age was 66 years, and 84% of patients were male. Patients were treated with neoadjuvant chemotherapy followed by radical cystectomy or adjuvant chemotherapy after surgery between August 2021 and March 2025. The Prognostic Nutritional Index (PNI) was calculated using pretreatment laboratory values. ROC analysis was used to determine the optimal PNI cut-off for predicting mortality, and the derived threshold (49.97) was applied for stratification in all survival analyses. Survival outcomes were evaluated using the Kaplan–Meier method and compared using the log-rank test. Multivariate Cox proportional hazards regression was used to identify independent prognostic factors.
Results
Among 262 patients, 138 (52.7%) received NAC, and 124 (47.3%) received AC. Median follow-up was 33.6 months (95% CI: 29.4–37.8). No statistically significant differences in OS (p = 0.388) or PFS (p = 0.499) were observed between treatment groups. In univariate analyses, nodal stage, pathological complete response (pCR), and PNI were significantly associated with both OS and PFS. In multivariate analysis, low PNI (≤49.97) remained an independent predictor of mortality (HR 1.78, 95% CI 1.04–3.38; p = 0.044), while N3 nodal stage independently predicted disease progression (HR 5.92, 95% CI 1.06–32.84; p = 0.042).
Conclusions
In this multicenter real-world cohort, nodal stage and systemic inflammatory-nutritional status were key determinants of prognosis in patients with locally advanced bladder cancer receiving perioperative chemotherapy. PNI emerged as an independent predictor of overall survival, suggesting that host-related biomarkers may improve prognostic stratification beyond traditional clinicopathological factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology Clinic, Faculty of Medicine, Kocaeli City Hospital, İzmit 41060, Turkey.
- Department of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey.
- Department of Medical Oncology, İzmir Çiğli Training and Research Hospital, İzmir 35620, Turkey.
- Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara 06200, Turkey.
- Department of Medical Oncology, Afyonkarahisar Health Sciences University, Kocaeli 03030, Turkey.
- Department of Medical Oncology, Karadeniz Technical University Farabi Hospital, Trabzon 61080, Turkey.
ORCID-Profile: Anıl Karakayalı, Mustafa Seyyar, Elif Şahin, Berkan Karabuğa, Öztürk Ateş, Meltem Baykara, Görkem Turhan, Hikmet Akar, Ferhat Ekinci, Berkay Yeşilyurt, Sinem Akbaş, Ali Kalem, Mesut Yılmaz, Ece Demirdelen, Oğuzhan Yıldız, Özgür Tanrıverdi, Nadiye Sever, Umut Kefeli
Zitieren
APA
Karakayalı, A., Seyyar, M., Şancı, P. C., Şahin, E., Karabuğa, B., Ateş, Ö., Bacak, B., Baykara, M., Turhan, G., Akar, H., Ekinci, F., Eryılmaz, M. K., Yeşilyurt, B., Akbaş, S., Kalem, A., Yılmaz, M., Demirdelen, E., Taş, S., Yıldız, O., …, & Uygun, K. (2026). Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study. Medicina, 62(5), 992. https://doi.org/10.3390/medicina62050992
Vancouver
Karakayalı A, Seyyar M, Şancı PC, Şahin E, Karabuğa B, Ateş Ö, et al. Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study. Medicina. 2026;62(5):992. doi:10.3390/medicina62050992
BibTeX
@article{Karakayal2026,
author = {Karakayalı, Anıl and Seyyar, Mustafa and Şancı, Pervin Can and Şahin, Elif and Karabuğa, Berkan and Ateş, Öztürk and Bacak, Burcu and Baykara, Meltem and Turhan, Görkem and Akar, Hikmet and Ekinci, Ferhat and Eryılmaz, Melek Karakurt and Yeşilyurt, Berkay and Akbaş, Sinem and Kalem, Ali and Yılmaz, Mesut and Demirdelen, Ece and Taş, Semra and Yıldız, Oğuzhan and Tanrıverdi, Özgür and Sever, Nadiye and Çabuk, Devrim and Kefeli, Umut and Uygun, Kazım},
title = {Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {992},
doi = {10.3390/medicina62050992}
}
EUVIMED